IL33 and myeloid sarcoma: The cell expression profile of IL-33 and ST2 was mapped in the brain tissues of patients with MS and corresponding controls via immunohistochemistry, and the results indicate that IL-33 may play a crucial role in MS occurrence and development by inhibiting myelination and oligodendrocyte expression in the CNS (60).